Modulation of the cytokine response in human monocytes by Mycobacterium leprae phenolic glycolipid-1

Journal of Interferon and Cytokine Research

Volumn 32, Issue 1, 2012, Pages 27-33

  Manca, Claudia ^a   Peixoto, Blas ^a   Malaga, Wladimir ^b,c   Guilhot, Christophe ^b,c   Kaplan, Gilla ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOLIC GLYCOLIPID I;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEPROSY; MONOCYTE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIGENS, BACTERIAL; CHEMOKINES; CYTOKINES; GLYCOLIPIDS; HUMANS; IMMUNITY, INNATE; MONOCYTES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE;

EID: 84855768267     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0044     Document Type: Article

References (33)

1. Bhandarkar SS, Cohen C, Kuruvila M, Rea TH, Mackelfresh JB, Lee DJ, Modlin RL, Arbiser JL. 2007. Angiogenesis in cutaneous lesions of leprosy: implications for treatment. Arch Dermatol 143:1527-1529. (Pubitemid 350277768)
2. Charlab R, Sarno EN, Chatterjee D, Pessolani MC. 2001. Effect of unique Mycobacterium leprae phenolic glycolipid-I (PGL-I) on tumour necrosis factor production by human mononuclear cells. Lepr Rev 72:63-69. (Pubitemid 32367443)
3. Chatterjee D, Bozic CM, Knisley C, Cho SN, Brennan PJ. 1989. Phenolic glycolipids of Mycobacterium bovis: new structures and synthesis of a corresponding seroreactive neoglycoprotein. Infect Immun 57:322-330. (Pubitemid 19046349)
4. Daffé M, Laneelle MA, Lacave C, Laneelle G. 1988. Monoglycosyldiacylphenol- phthiocerol of Mycobacterium tuberculosis and Mycobacterium bovis. Biochim Biophys Acta 958: 443-449.
5. Dhungel S, Ranjit C, Sapkota BR, Macdonald M. 2008. Role of PGL-I of M. leprae in TNF-alpha production by in vitro whole blood assay. Nepal Med Coll J 10:1-3.
6. Dinarello CA, Thompson RC. 1991. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 12:404-410.
7. Fiallo P, Clapasson A, Favre A, Pesce C. 2002. Overexpression of vascular endothelial growth factor and its endothelial cell receptor KDR in type 1 leprosy reaction. Am J Trop Med Hyg 66:180-185. (Pubitemid 34755651)
8. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montano M, Barnes PF, Selman M, Granados J. 2005. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 202:1649-1658. (Pubitemid 41815871)
9. Hashimoto K, Maeda Y, Kimura H, Suzuki K, Masuda A, Matsuoka M, Makino M. 2002. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigenpresenting function. Infect Immun 70:5167-5176.
10. Hunter SW, Brennan PJ. 1981. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol 147:728-735. (Pubitemid 12226295)
11. Hunter SW, Fujiwara T, Brennan PJ. 1982. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem 257:15072-15078. (Pubitemid 13164857)
12. Lockwood DN, Colston MJ, Khanolkar-Young SR. 2002. The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions. Am J Trop Med Hyg 66:409-415. (Pubitemid 34810496)
13. Manca C, Paul S, Barry CE 3rd, Freedman VH, Kaplan G. 1999. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 67:74-79. (Pubitemid 29021631)
14. Mehra V, Brennan PJ, Rada E, Convit J, Bloom BR. 1984. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 308:194-196. (Pubitemid 14129561)
15. Misch EA, Berrington WR, Vary JC Jr., Hawn TR. 2010. Leprosy and the human genome. Microbiol Mol Biol Rev 74:589-620.
16. Murray RA, Siddiqui MR, Mendillo M, Krahenbuhl J, Kaplan G. 2007. Mycobacterium leprae inhibits dendritic cell activation and maturation. J Immunol 178:338-344. (Pubitemid 46033617)
17. Neill MA, Klebanoff SJ. 1988. The effect of phenolic glycolipid-1 from Mycobacteriuim leprae on the antimicrobial activity of human macrophages. J Exp Med 167:30-42. (Pubitemid 18093691)
18. Ng V, Zanazzi G, Timpl R, Talts JF, Salzer JL, Brennan PJ, Rambukkana A. 2000. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 103:511-524.
19. Nomaguchi H, Dohi Y, Ohno N, Fujiwara T, Ito T. 1989. Suppression of Con A response of mouse lymphocytes with unique M. leprae glycolipid. Nippon Rai Gakkai Zasshi 58:191-196. (Pubitemid 20195987)
20. Prasad HK, Mishra RS, Nath I. 1987. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type. J Exp Med 165:239-244. (Pubitemid 17223684)
21. Ridley DS, Jopling WH. 1966. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34:255-273.
22. Schlesinger LS, Horwitz MA. 1991. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J Exp Med 174:1031-1038.
23. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. 2006. The continuing challenges of leprosy. Clin Microbiol Rev 19:338-381.
24. Silva CL, Faccioli LH, Foss NT. 1993. Suppression of human monocyte cytokine release by phenolic glycolipid-I of Mycobacterium leprae. Int J Lepr Other Mycobact Dis 61:107-108. (Pubitemid 23215513)
25. Sinsimer D, Fallows D, Peixoto B, Krahenbuhl J, Kaplan G, Manca C. 2010. Mycobacterium leprae actively modulates the cytokine response in naive human monocytes. Infect Immun 78:293-300.
26. Suzuki K, Fukutomi Y, Matsuoka M, Torii K, Hayashi H, Takii T, Oomoto Y, Onozaki K. 1993. Differential production of interleukin 1 (IL-1), IL-6, tumor necrosis factor, and IL-1 receptor antagonist by human monocytes stimulated with Mycobacterium leprae and M. bovis BCG. Int J Lepr Other Mycobact Dis 61:609-618. (Pubitemid 24129420)
27. Tabouret G, Astarie-Dequeker C, Demangel C, Malaga W, Constant P, Ray A, Honore N, Bello NF, Perez E, Daffe M, Guilhot C. 2010. Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. PLoS Pathog 6:e1001159.
28. Truman RW, Krahenbuhl JL. 2001. Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis 69:1-12. (Pubitemid 32667330)
29. Vachula M, Holzer TJ, Andersen BR. 1989. Suppression of monocyte oxidative response by phenolic glycolipid I of Mycobacterium leprae. J Immunol 142:1696-1701. (Pubitemid 19086341)
30. Vachula M, Holzer TJ, Kizlaitis L, Andersen BR. 1990a. Effect of Mycobacterium leprae's phenolic glycolipid-I on interferongamma augmentation of monocyte oxidative responses. Int J Lepr Other Mycobact Dis 58:342-346. (Pubitemid 20234063)
31. Vachula M, Worobec S, Andersen BR. 1990b. A comparison of monocyte oxidative responses in leprosy patients and healthy subjects as influenced by mycobacterial lipid pretreatment. Int J Lepr Other Mycobact Dis 58:534-539. (Pubitemid 20319087)
32. Vissa VD, Brennan PJ. 2001. The genome of Mycobacterium leprae: a minimal mycobacterial gene set. Genome Biol. 2(8):Reviews1023
33. Yamamura M, Wang XH, Ohmen JD, Uyemura K, Rea TH, Bloom BR, Modlin RL. 1992. Cytokine patterns of immunologically mediated tissue damage. J Immunol 149:1470-1475.